Stem Cell Market Analysis, Market Size, Share, Regional Outlook, Industry Trends, Competitive Strategies and Segment Forecasts, 2012 to 2020

Submitted by: Submitted by

Views: 10

Words: 1160

Pages: 5

Category: Business and Industry

Date Submitted: 11/04/2015 10:39 PM

Report This Essay

Hexa Research Inc.

Industry Research,Custom Research & Consulting

Stem Cell Market Analysis, Market Size, Share, Regional

Outlook, Industry Trends, Competitive Strategies And

Segment Forecasts, 2012 To 2020

Company Insight

Increasing prevalence of chronic diseases such as diseases related to liver, kidney and cardiovascular,

are expected to propel the market for stem cell. Stem cells are the undifferentiated cells having the

capacity to reproduce among themselves, which can perform wide number of functions. Rising demand

for regenerative medical treatments coupled with increasing investment in research and development

of healthcare sector is likely to drive the market in coming five years.

Browse Detail Report With TOC @ http://www.hexaresearch.com/research-report/stem-cellindustry/

Rising government support in medical sector, growing personal disposable income, continuously

increasing medical tourism and growth of health insurance are likely to drive the stem cell market over

the forecast period. Along with the boosting factors, the stem cell market also faces setbacks which are

pulling the growth of this market like government norms against unethical harvesting and high cost of

treatment for stem cell. NIH (National Institute of Health) is providing huge funds for research and

Hexa Research Inc.

Industry Research,Custom Research & Consulting

development of stem cell. In 2011 it had spent about USD 1.3 billion and in 2012 NIH spent almost USD

1.46 billion. Furthermore, stem cell therapies are granted the orphan drug status due to

commercialization of these techniques.

Presence of large unserved market lying idle in developing nations provide significant opportunity for

growth of stem cell market over the forecast period. Rising outsourcing and offshoring of research work

in developing nations is also likely to offer significant growth platform to produce same quality of

devices and drugs maintaining the same quality. Increasing worldwide prevalence of...